|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02192 MEDLIVE
Nominal 
14.100 +0.030 (+0.213%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 312,035 | 28.176% | 558,455 | 412,004 | 314,054 | 284,440 |
| Cost of Sales | (128,087) | 33.266% | (231,233) | (160,669) | (101,313) | (83,706) |
| Gross Profit | 183,948 | 24.855% | 327,222 | 251,335 | 212,741 | 200,734 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 5 | 12 | (2) | |
| Profit / (Loss) before Taxation | 166,477 | 5.267% | 340,474 | 253,132 | 135,037 | 69,927 | |
| Taxation | (6,071) | 11.558% | (10,173) | (1,372) | (8,616) | (24,682) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (5,068) | -15.350% | (15,155) | (9,459) | (9,100) | (4,629) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 155,338 | 5.874% | 315,146 | 242,301 | 117,321 | 40,616 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (93,783) | -8.482% | (203,933) | (183,523) | (65,711) | (7,174) |
| Depreciation & Amortisation | -- | -- | 15,600 | 9,371 | 8,987 | 6,149 |
| Directors' Emoluments | -- | -- | 9,171 | 10,048 | 13,372 | 11,934 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 21.200 | 5.055% | 43.230 | 33.560 | 16.420 | 6.590 |
| DPS (cts) | 11.660 | -- | 25.710 | 23.150 | 6.540 | 1.700 |
| Dividend Payout Ratio (%) | 55.000% | -- | 59.473% | 68.981% | 39.829% | 25.797% |
| Cash flow per share ($) | -- | -- | 0.149 | 0.141 | 0.108 | 0.072 |
| NBV per share ($) | 6.603 | -- | 6.548 | 6.324 | 6.135 | 5.536 |
| Remarks: | Real time quote last updated: 29/08/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 155,338 |
| %Change | 5.874% |
| EPS / (LPS) | RMB 0.212 |
| NBV Per Share (¥) | RMB 6.603 |